Vertex Pharmaceuticals Inc / Ma

Vestmark Advisory Solutions, Inc. VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/6/2026

Shares

7,822

Value ($000)

3,546

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/6/2026	3,546	0.0%	7,822	12/31/2025
2025 Q3	11/10/2025	3,692	0.1%	9,428	9/30/2025
2025 Q2	8/6/2025	3,901	0.1%	8,763	6/30/2025
2025 Q1	5/13/2025	6,006	0.2%	12,388	3/31/2025
2024 Q4	2/6/2025	2,333	0.1%	5,793	12/31/2024
2024 Q3	11/14/2024	2,855	0.1%	6,139	9/30/2024
2024 Q2	8/12/2024	2,865	0.1%	6,113	6/30/2024
2024 Q1	5/15/2024	628	0.0%	1,503	3/31/2024
2023 Q4	2/6/2024	612	0.0%	1,505	12/31/2023
2023 Q3	11/6/2023	580	0.0%	1,669	9/30/2023
2023 Q2	8/7/2023	5,983	0.2%	17,001	6/30/2023
2023 Q1	5/9/2023	5,426	0.2%	17,220	3/31/2023
2022 Q4	1/20/2023	5,185	0.3%	17,954	12/31/2022
2022 Q3	11/3/2022	5,257	0.3%	18,158	9/30/2022
2022 Q2	8/4/2022	5,284	0.3%	18,749	6/30/2022
2022 Q1	4/27/2022	5,160	0.3%	19,773	3/31/2022
2021 Q4	1/31/2022	4,388	0.2%	19,982	12/31/2021
2021 Q3	11/15/2021	3,689	0.2%	20,339	9/30/2021
2021 Q2	8/9/2021	4,182	0.3%	20,739	6/30/2021
2021 Q1	5/10/2021	4,199	0.4%	19,542	3/31/2021
2020 Q4	2/4/2021	3,671	0.4%	15,533	12/31/2020
2020 Q3	10/19/2020	3,761	0.5%	13,821	9/30/2020
2020 Q2	8/13/2020	3,395	0.5%	11,693	6/30/2020
2020 Q1	5/6/2020	2,588	0.5%	10,876	3/31/2020
2019 Q4	2/14/2020	2,497	0.5%	11,406	12/31/2019